Back to Rankings

CATX

Perspective TherapeuticsC
NYSE American / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
CATX vs peer average
59/100
CATX vs. peer average (C vs. D)
Grade spread
A 1 · B 1 · C 2 · D 5 · F 2
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

CCCC is the first available peer comparator.

Clinical-stage oncology biotech with event-driven valuation swings; useful as a loose readout and financing-risk comparator, though not a direct radiopharma peer.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerCCCCC4 Therapeutics
CATX
Perspective Therapeutics
CCCC
C4 Therapeutics
Grade
C
C
Momentum
8
79
Value
41
41
Sentiment
100
36
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Mixed

Grade position vs CCCC

CATX / CCCC
Grade Position
In line
CATX vs. peer average (C vs. D)
59/100
Momentum
8
CCCC
Value
41
CATX
Sentiment
100
CATX

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs CATX
1
CCCC
CCCC
C
60/100
Even
2
EDIT
EDIT
C
60/100
Even
3
TNXP
TNXP
F
20/100
+2
4
PALI
Palisade Bio Inc Common
B
80/100
-1
5
ORGO
Organogenesis Holdings Inc Class A Common
D
40/100
+1
CCCC is the first peer returned for this comparison set.